Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Radiochemotherapy in Local Advanced Squamous Cell Carcinoma of the Esophagus With Weekly Cetuximab Plus Oxaliplatin Plus Continuous IV. 5-FU and Conventional Fractionated External Multi-Field Irradiation up to 45 Gray. A Phase I/II Study

NCT00425425 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT00425425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00425425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Radiochemotherapy in Local Advanced Squamous Cell Carcinoma of the Esophagus With Weekly Cetuximab Plus Oxaliplatin Plus Continuous IV. 5-FU and Conventional Fractionated External Multi-Field Irradiation up to 45 Gray. A Phase I/II Study
Lead sponsor
Technical University of Munich
Phase
Phase 1/2
Overall status
Unknown status
Start date
July 31, 2006
Completion date
May 31, 2015
Enrollment
43 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer